| Q43107563 | A 19-year-old male with palpitations |
| Q39000875 | A European myocardial (123)I-mIBG cross-calibration phantom study. |
| Q83145177 | A step forward in the use of SPECT imaging with I-123 MIBG |
| Q77335579 | Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot |
| Q44138116 | Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging |
| Q40473734 | Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Review |
| Q77335464 | Arrhythmogenic right ventricular cardiomyopathy |
| Q83207626 | Arrhythmogenic right ventricular cardiomyopathy a still underrecognized clinic entity |
| Q30489889 | Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study |
| Q34769980 | Arrhythmogenic right ventricular cardiomyopathy/dysplasia. |
| Q38046512 | Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification |
| Q33157574 | Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification |
| Q73458019 | Arrhythmogenic right ventricular cardiomyopathy: time for a new look |
| Q42332020 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment |
| Q90602761 | Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study |
| Q35912361 | Cardiac neurotransmission SPECT imaging. |
| Q28077143 | Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation |
| Q26784294 | Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy |
| Q43996555 | Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy |
| Q47822565 | Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. |
| Q44470510 | Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias |
| Q44604292 | Clinical Significance and Contributing Factors of Long‐Term Variability in Induced Ventricular Tachyarrhythmias |
| Q34282145 | Clinical characteristics and catheter ablation of left ventricular outflow tract tachycardia |
| Q34390641 | Clinical use of nuclear cardiology in the assessment of heart failure |
| Q92132136 | Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue |
| Q44238935 | Immunohistochemical-scintigraphic correlation of sympathetic cardiac innervation in postischemic left ventricular aneurysms |
| Q40334389 | Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation |
| Q42948999 | Impaired Cardiac Sympathetic Innervation and Myocardial Perfusion Are Related to Lethal Arrhythmia: Quantification of Cardiac Tracers in Patients with ICDs |
| Q33160170 | Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome |
| Q73565448 | Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing |
| Q71975716 | Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy |
| Q77361710 | Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy |
| Q35587934 | Long-range silencing and position effects at telomeres and centromeres: parallels and differences |
| Q34531254 | MIBG imaging |
| Q77542228 | Mismatch between myocardial accumulation of 123I-MIBG and 99mTc-MIBI and late ventricular potentials in patients after myocardial infarction: association with the development of ventricular arrhythmias |
| Q31929065 | Modulation of ventricular repolarization and R-R interval is altered in patients with globally impaired cardiac 123I-MIBG uptake |
| Q51321052 | Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure. |
| Q36724791 | Neuronal imaging using SPECT. |
| Q40221027 | Neuronal imaging using SPECT. |
| Q33149131 | Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. |
| Q74552190 | Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology |
| Q33940862 | Nonsustained ventricular tachycardia |
| Q55222178 | Polymorphism of SLC6A2 gene does not influence outcome of myocardial 123I-mIBG scintigraphy in patients with chronic heart failure. |
| Q53784508 | Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging. |
| Q37980391 | Prevalence and spectrum diseases predisposing to sudden cardiac death: are they the same for both the athlete and the nonathlete? |
| Q46389352 | Radionuclide imaging tools for understanding arrhythmia mechanisms |
| Q41522913 | Recent advances in nuclear cardiology in the study of coronary artery disease |
| Q60607105 | Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography |
| Q44616026 | Relation between Microvolt-Level T-Wave Alternans and cardiac sympathetic nervous system abnormality using iodine-123 metaiodobenzylguanidine imaging in patients with Idiopathic Dilated cardiomyopathy |
| Q73226844 | Right ventricular abnormalities assessed by myocardial single-photon emission computed tomography using technetium-99m sestamibi/tetrofosmin in right ventricle-originated ventricular tachyarrhythmias |
| Q73861647 | Right ventricular cardiomyopathy: diffuse dilatation, focal dysplasia or biventricular disease |
| Q41625271 | Role of Bilateral Sympathectomy in the Treatment of Refractory Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy |
| Q41111174 | Scintigraphic evaluation of cardiac autonomic innervation |
| Q70953772 | Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy |
| Q74011506 | Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG): is there a clinical application? |
| Q33175413 | Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. |
| Q35786576 | Sudden cardiac death in young athletes; a literature review and special considerations in Asia. |
| Q39548660 | The role of nuclear cardiac imaging in risk stratification of sudden cardiac death |
| Q73798643 | Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus |
| Q72180295 | Transfer from PET to SPET in cardiology, but the unit of reference is still the patient |
| Q26799143 | Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement |
| Q26799094 | Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement |
| Q33940845 | Ventricular arrhythmias in normal hearts |
| Q74569448 | [Arrhythmogenic right ventricular cardiomyopathy. Etiology, diagnosis and therapy] |
| Q80391626 | [Update in arrhythmogenic right ventricular cardiomyopathy: genetic, clinical presentation and risk stratification] |